Competitors Push New Data In Coverage Battle For T-Wave Alternans Tests
This article was originally published in The Gray Sheet
Executive Summary
Industry and physician stakeholders say CMS missed a key study in considering its coverage policy for noninvasive tests that help assess a patient's need for an implantable defibrillator. Competing test makers have different views on how the new data should be interpreted
You may also be interested in...
CMS Considers Coverage For GE’s Risk-Predictor Tool For Sudden Cardiac Death
The Medicare agency says it is reconsidering a 2008 national noncoverage policy for GE Healthcare’s microvolt T-Wave alternans testing tool for evaluating risk of sudden cardiac death, and the potential need for an ICD. An alternative MTWA technique is already covered, but the company that makes that product is going out of business.
CMS Rejects Boston Scientific And GE Requests To Expand Coverage
CMS issued two national coverage decisions May 12, both declining manufacturers' requests to expand Medicare coverage of device technologies
CMS Rejects Boston Scientific And GE Requests To Expand Coverage
CMS issued two national coverage decisions May 12, both declining manufacturers' requests to expand Medicare coverage of device technologies